Sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes appear to be as safe and effective in people aged 65 years and older as in younger individuals, new research suggests. Findings from a real-world observational study of 50 older adults with type 2 diabetes were recently presented here at the International… Read More
John P. DeVincenzo, MD, from the University of Tennessee College of Medicine and the Children’s Foundation Research Institute at Le Bonheur Children’s Hospital, Memphis, Tennessee, and colleagues published their findings in the November 19 issue of the New England Journal of Medicine.
“Mirror therapy actually does work, and it seems to have a very rapid response,” said Jack Tsao, MD, DPhil, professor of neurology at the University of Tennessee Health Science Center in Memphis.
One of those who doesn’t see the need for change is Dr Samuel E Dagogo-Jack (division of endocrinology, diabetes, and metabolism, and director, Clinical Research Center, University of Tennessee Health Science Center, Memphis), who is the incoming president, medicine and science, of the American Diabetes Association.
